Inventor · disambiguated record
Erik Hans Manting
Also filed as: MANTING ERIK HANS
5 granted patents·8 pending applications·5 citations·filing 2020–2024
69Inventor score
Top patents by PatentIndex Score
13 records- 0182US11052144B2Methods of tumor vaccinationDCPRIME B V·Filed 2020·Granted Jul 6, 2021·2 cites·20 claims
- 0278US12091681B2Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapyMENDUS B V·Filed 2021·Granted Sep 17, 2024·1 cites·30 claims
- 0377US11071778B2Combination product for use in tumor vaccinationDCPRIME B V·Filed 2020·Granted Jul 27, 2021·2 cites·20 claims
- 0467US2025084376A1Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapyMENDUS B V·Filed 2024·Application pending·0 cites
- 0563US12397055B2Methods of tumor vaccinationMENDUS B V·Filed 2022·Granted Aug 26, 2025·0 cites·26 claims
- 0660US12364758B2Use of leukemia-derived cells in ovarian cancer vaccinesMENDUS B V·Filed 2021·Granted Jul 22, 2025·0 cites·13 claims
- 0758US2024002800A1Use of leukemia-derived cells for enhancing natural killer (nk) cell therapyMENDUS B V·Filed 2023·Application pending·0 cites
- 0857US2023355760A1Modified cells of leukemic origin and a pd-l1 antibody for enhancing the efficacy of cancer cell therapyMENDUS B V·Filed 2023·Application pending·0 cites
- 0956US2021401961A1Methods of tumor vaccinationDCPRIME B V·Filed 2021·Application pending·0 cites
- 1053US2022305100A1Methods of vaccination and use of cd47 blockadeDCPRIME B V·Filed 2022·Application pending·0 cites
- 1152US2022023406A1Combination product for use in tumor vaccinationDCPRIME B V·Filed 2021·Application pending·0 cites
- 1250US2022168407A1Use of tumor-independent antigens in immunotherapiesDCPRIME B V·Filed 2021·Application pending·0 cites
- 1348US2021322471A1In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapyDCPRIME B V·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erik Hans Manting files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →